Nerve block may cut opioid use after pelvic surgery
NCT ID NCT06309693
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a quadratus lumborum (QL) nerve block can reduce pain and the need for opioid painkillers after robotic surgery for pelvic organ prolapse. 70 women were randomly assigned to receive either the QL block or standard enhanced recovery care. Researchers measured pain scores and opioid use right after surgery to see if the block offered better pain control.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Quadratus Lumborum (QL) nerve block
- What this could lead to
- If effective, the QL block could become a standard option to reduce pain and opioid use after robotic pelvic surgery.
- What could go wrong
- This is a small, completed study (70 participants) comparing two existing approaches, so results may not apply to all patients or surgeries. Nerve blocks carry rare risks like infection or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
70 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Women undergoing robotic-assisted sacrocolpopexy with concurrent robotic assisted supracervical or total laparoscopic hysterectomy or robotic assisted sacrocolpopexy after previous hysterectomy 2. Age 18 years old or greater 3. Fluency and literacy in English 4. Capacity to provide consent Exclusion Criteria: 1\. Lack fluency and literacy in English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pelvic organ prolapse are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which nerve block wins the battle against chest surgery pain?
- Which nerve block wins the battle against Post-Surgery pain?
- Can strength training steady the walk and strengthen the pelvic floor after menopause?
- Can a pre-surgery paracetamol and tramadol combo beat fentanyl for day-case pain?
- Can a biological mesh improve pelvic floor surgery?
- Insulin eye drops put to the test for faster corneal healing